Pronov
Software · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Ogunbiyi St, Sydney, New South Wales,...Phone Number
+234 9090002653Website
www.pronov.coRevenue
<$5 MillionIndustry
About Pronov
Is Pronov your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Pronov has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Pronov had a recent Job posting/layoffs
Product Launch: Get notified when Pronov launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pronov recently announced quarterly report
Pronov, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Pronov is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pronov
Check if Pronov has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Pronov as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Pronov is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Pronov is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Pronov.
Pronov Tech Stack
A closer look at the technologies used by Pronov
Top Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Pronov
Pronov provides accurate, interactive and easy to understand Business and Financial reports. Pronov LLC is a startup that was launched to solve the problems within the supply chain network of medical devices and pharmaceutical products. We were originally referred to as Project NerveOnVerge which was conceived in 2014 as a response to Bill & Melind... Read More